← Leaderboards
Melda Onal
Univ Of Arkansas For Med Scis
$1,749,934
Attributed
$1,749,934
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $431.3K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,749,934 · 4
By mechanism
P20$1,387,770 · 3
R21$362,164 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Arkansas For Med Scis
Same institution · by research overlap
- Roy Morello$4,669,541
- Charles A O'Brien$15,608,722
- Jinhu Xiong$3,202,999
- Zufeng Ding$1,804,000
- Maria Jose Almeida$5,489,226
Others in their field
Other Emerging Leaders on “Cell Type”
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Thomas Denny · Duke University$19,381,749
- Tomasz Nowakowski · University Of California, San Francisco$18,472,946
- Hemali Phatnani · New York University School Of Medicine$18,358,586
- Rui M. Costa · Columbia University Health Sciences$13,762,381
Research focus
Cell TypeOsteoblastsOsteocytesPathologyCellsBone RemodelingIn VivoSkeletalBoneProgenitorOsteoblast DifferentiationApoptosisMouse ModelMusculoskeletal DiseasesCell LineageMolecular ChaperonesMechanical LoadCollagenKnockout MiceMediatingCessation Of LifeCellular StressFunctional DisorderEndoplasmic Reticulum Stress
Grant awards (7)
The role of autophagy in bone remodeling$274,929
P20 · FY2025 · GM · contact PI
The role of autophagy in bone remodeling$309,631
P20 · FY2024 · GM · contact PI
The role of autophagy in bone remodeling$294,196
P20 · FY2023 · GM · contact PI
The role of autophagy in the osteoblast lineage cells$239,902
P20 · FY2022 · GM · contact PI
The role of autophagy in the osteoblast lineage cells$269,112
P20 · FY2021 · GM · contact PI
CRISPR inhibition as an alternate for Cre-loxP$162,184
R21 · FY2021 · AR · contact PI
CRISPR inhibition as an alternate for Cre-loxP$199,980
R21 · FY2020 · AR · contact PI